Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency

Clinical Endocrinology

Volumn 56, Issue 4, 2002, Pages 431-437

  Ahmad, Aftab M ^a   Hopkins, Marion T ^a   Weston, Philip J ^a   Fraser, William D ^a   Vora, Jiten P ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HEART RATE; HORMONE SUBSTITUTION; HUMAN; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; TOTAL BODY WATER;

ADENOMA; ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY COMPOSITION; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES;

EID: 0036227824     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01491.x     Document Type: Article

References (39)

1. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement
2. Aneroid sphygmomanometers. An assessment of accuracy at a university hospital and clinics
3. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study
4. Increased cerebrovascular mortality in patients with hypopituitarism
5. Cardiovascular and renal effects of growth hormone
6. Abnormal vascular reactivity in growth hormone deficiency
7. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
8. Quantitative analysis of the 24-hour blood pressure and heart rate patterns in young men
9. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension
10. Twenty-four-hour blood pressure profile in Addison's disease
11. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension
12. Rhythms and blood pressure
13. Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure
14. Prognostic significance of ambulatory blood pressure
15. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients
16. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: Studies in GH-deficient adults
17. Prognostic significance of blood pressure and heart rate variabilities: The Ohasama study
18. The importance of blood pressure variability in hypertension
19. Alerting reaction and rise in blood pressure during measurement by physician and nurse
20. White-coat hypertension: Misnomers, misconceptions and misunderstandings. What should we do next?
21. Long-term reproducibility of ambulatory blood pressure
22. Chronolab: An interactive software package for chronobilogic time series analysis written for the Macintosh computer
23. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: A controlled experimental study
24. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man
25. Age-associated changes in blood pressure in a longitudinal study of healthy men and women
26. How common is white coat hypertension?
27. Heart rate and mortality
28. Premature mortality due to cardiovascular disease in hypopituitarism
29. Growth hormone and the heart
30. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency
31. Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells
32. Absence of nocturnal decrease in blood pressure in 24-hour blood pressure monitoring: An indication of secondary hypertension
33. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults
34. Reproducibility of non-invasive and intra-arterial blood pressure monitoring: Implications for studies on antihypertensive treatment
35. Normal and aberrant growth
36. Blood pressure monitoring. Task force III: Target-organ damage, morbidity and mortality
37. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension
38. Blood pressure effects of the angiotensin II receptor blocker, losartan
39. The role of ambulatory blood pressure monitoring in clinical practice